Synthesis of F16 conjugated with 5-fluorouracil and biophysical investigation of its interaction with bovine serum albumin by a spectroscopic and molecular modeling approach
作者:Chen Xiang、Dong-Wei Li、Zu-De Qi、Feng-Lei Jiang、Yu-Shu Ge、Yi Liu
DOI:10.1002/bio.2447
日期:2013.11
5-Fluorouracil (5-FU) has been widely used as a chemotherapy agent in the treatment of many types of solid tumors. Investigation of its antimetabolites led to the development of an entire class of fluorinated pyrimidines. However, the toxicity profile associated with 5-FU is significant and includes diarrhea, mucositis, hand–foot syndrome and myelosuppression. In aiming at reducing of the side effects of 5-FU, we have designed and synthesized delocalized lipophilic cations (DLCs) as a vehicle for the delivery of 5-FU. DLCs accumulate selectively in the mitochondria of cancer cells because of the high mitochondrial transmembrane potential (ΔΨm). Many DLCs exhibited anti-cancer efficacy and were explored as potential anti-cancer drugs based on their selective accumulation in the mitochondria of cancer cells. F16, the DLC we used as a vehicle, is a small molecule that selectively inhibits tumor cell growth and dissipates mitochondrial membrane potential. The binding of the conjugate F16–5-FU to bovine serum albumin (BSA) was investigated using spectroscopic and molecular modeling approaches. Fluorescence quenching constants were determined using the Stern–Volmer equation to provide a measure of the binding affinity between F16–5-FU and BSA. The activation energy of the interaction between F16–5-FU and BSA was calculated and the unusually high value was discussed in terms of the special structural block indicated by the molecular modeling approach. Molecular modeling showed that F16–5-FU binds to human serum albumin in site II, which is consistent with the results of site-competitive replacement experiments. It is suggested that hydrophobic and polar forces played important roles in the binding reaction, in accordance with the results of thermodynamic experiments. Copyright © 2012 John Wiley & Sons, Ltd.
5-氟尿嘧啶(5-FU)已被广泛用作治疗多种实体瘤的化疗药物。通过对其抗代谢物的研究,开发出了一整类氟化嘧啶。然而,5-FU 的毒性很大,包括腹泻、粘膜炎、手足综合征和骨髓抑制。为了减少 5-FU 的副作用,我们设计并合成了脱定位亲脂阳离子(DLCs),作为 5-FU 的载体。由于线粒体跨膜电位(ΔΨm)较高,DLCs 可选择性地聚集在癌细胞的线粒体中。许多 DLC 具有抗癌功效,并根据其在癌细胞线粒体中的选择性积累被探索为潜在的抗癌药物。我们用作载体的 DLC F16 是一种选择性抑制肿瘤细胞生长并降低线粒体膜电位的小分子。我们利用光谱和分子建模方法研究了 F16-5-FU 与牛血清白蛋白(BSA)的结合。利用斯特恩-沃尔默方程测定了荧光淬灭常数,以衡量 F16-5-FU 与 BSA 之间的结合亲和力。计算了 F16-5-FU 和 BSA 之间相互作用的活化能,并根据分子建模方法所显示的特殊结构块讨论了异常高的活化能值。分子建模显示,F16-5-FU 与人血清白蛋白结合的位点是位点 II,这与位点竞争性置换实验的结果一致。热力学实验结果表明,疏水作用力和极性作用力在结合反应中发挥了重要作用。Copyright © 2012 John Wiley & Sons, Ltd. All Rights Reserved.